Alnylam Pharmaceuticals
Price & Volume
Stats
See moreOpen | $166.73 |
Previous Close | $159.89 |
Day Range | $160.48-$170.03 |
52W Range | $156.00-$479.79 |
Market Cap | $21.1B |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $5B |
Revenue Growth (YoY) | 16.7% |
Gross Profit (12 Mos) | $3.8B |
Diluted EPS | $19.80 |
News
See moreYahoo Finance • 4 hours ago
Alnylam to Webcast Presentation at the Jefferies Global Healthcare Conference
Yahoo Finance • 16 hours ago
What Could Alnylam Pharmaceuticals (ALNY) Five Year HELIOS B Data Change?
Yahoo Finance • 4 days ago
5 Best High Growth Stocks Outside Big Tech
Yahoo Finance • 5 days ago
BridgeBio's Heart Disorder Drug Attruby Faces Unanticipated Near-Term Tailwinds, UBS Says
About
CEO | Dr. Yvonne L. Greenstreet M.B.A., M.D. |
CFO | Mr. Jeffrey V. Poulton M.B.A. |
Address | 675 West Kendall Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 2,500 |